
https://nitter.gq/t.co/wVNdzgPo3V A continuous intelligence system that is actively watching regulatory, clinical, and competitive environments right now. $AIMN
Joined January 2022
- Tweets796
- Following116
- Followers794
- Likes215
Aimwell Partners retweeted
When someone asks AI for a clinic like yours, which name comes up?😅
Yours, or the practice down the street?
Stop guessing. See whether your practice gets named in a free scan. No signup.🥂
aimwellbio.com
🤖 Made with AI
Aimwell Partners retweeted
Your practice has a website.✅
But does it have a place in AI’s answer?
Those are two different things.
Find out whether AI names your practice—and who it names instead.
aimwellbio.com
$AIMN
🤖 Made with AI
Aimwell Partners retweeted
aimwellbio.com / We are adding some serious additions to the platform.
Aimwell Partners retweeted
aimwellbio.com/score
For qualified professionals
$AIMN
Aimwell Partners retweeted
aimwellbio.com/founding-phys…
For verified professionals
$AIMN
Aimwell Partners retweeted
Building the future of trusted healthcare intelligence requires more than technology. It requires the insight and leadership of the world’s most respected clinicians, scientists, and innovators.
Aimwell Partners retweeted
We are grateful to have Dr. Christopher Jones helping build our Advisory Board and connect world-class expertise across medicine, science, and technology.
The future of healthcare AI requires more than algorithms. It requires human intelligence behind the technology. $AIMN
Aimwell Partners retweeted
aimwellbio.com / Updates and upgrades. $AIMN ✅
Aimwell Partners retweeted
The coffee is brewing at AimwellBio. Our strategic advisor Doctor Chris Jones has been in the room with some of the most trusted names in clinical intelligence. When evidence meets infrastructure, everyone wins. Stay tuned
AimwellBio.com ✅
Aimwell Partners retweeted
The future of federated health intelligence isn’t built alone. It’s built in partnership. Conversations are happening that could reshape how clinicians access the best available evidence. More soon
$AIMN / AimwellBio.com
Aimwell Partners retweeted
Doctor Christopher Jones on where we’re headed: the next chapter of AimwellBio connects our platform to the global standard in evidence-based care. We’re not ready to say the name yet, but you’ll want to be watching
$AIMN / AimwellBio.com
Aimwell Partners retweeted
Know a clinician, researcher, regulatory expert, biopharma leader, or healthcare investor who should see what is moving?
Refer them to AimwellBio Observer access.
The room is forming.
Not everyone will qualify. AimwellBio.com / $AIMN
Aimwell Partners retweeted
The AI was confident.
The decision was wrong.
AimwellBio stress-tests healthcare intelligence before it becomes the meeting, the filing, or the capital move.
PROCEED. DELAY. KILL.
Before the damage.
Observer access is free after approval.
Aimwellbio.com $AIMN #ai
Aimwell Partners retweeted
Healthcare does not have an information problem.
It has a signal-trust problem.
AimwellBio is opening Observer access for credentialed professionals who want to see the intelligence layer forming before the room gets crowded.
Apply: aimwellbio.com/request-acces…
$AIMN #aihealthcare

















